Development of labeled thymidine analogs for imaging tumor proliferation

Nuclear Medicine and Biology

Volumn 23, Issue 1, 1996, Pages 17-22

  Shields, Anthony F ^a,b   Grierson, John R ^a   Kozawa, Susie M ^a   Zheng, Minna ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

5 fluoro 1 (2' deoxy 2' fluoro D ribofuranosyl)uracil; Positron tomography; Thymidine analogs

Indexed keywords

FLUORINE 18; THYMIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MOUSE; POSITRON EMISSION TOMOGRAPHY; TUMOR GROWTH;

EID: 0030045876     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(95)02005-5     Document Type: Article

References (16)

1. Codere J. A., Santi D. V., Matsuda A., Watanabe K. A. and Fox J. J. (1983) Mechanism of action of 2′,5-difluoro-1-arabinosyluracil. J. Med. Chem. 26, 1149-1152.
2. Codington J. F., Doerr I. L. and Fox J. J. (1964) Nucleosides. XVIII. Synthesis of 2′-fluorothymidine, 2′-fluorodeoxyuridine, and other 2′-halogeno-2′-deoxy nucleosides. J. Org. Chem. 29, 558-564.
3. Dimitrakopoulou A., Strauss L. G., Clorius J. H., Ostertag H., Schlag P., Heim M., Oberdorfer F., Helus F., Haberkorn U. and Van K. G. (1993) Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma. J. Nucl. Med. 34, 1075-1081.
4. 18F-5-fluorouracil. VII. J. Nucl. Med. 14, 63-64.
5. Hayakawa H., Takai F., Tanaka H., Miyasaka T. and Yamaguchi K. (1990) Diethylaminosulfur trifluoride (DAST) as a fluorinating agent of pyrimidine nucleosides having 2′,3′-vicinal diol system. Chem. Pharm. Bull. 38, 1136-1139.
6. 3H-deoxythymidine in tumor-bearing rats and mice. Eur. J. Nucl. Med. 10, 39-44.
7. Kubota K., Ishiwata K., Kubota R., Yamada S., Tada M., Sato T. and Ido T. (1991) Tracer feasibility for monitoring tumor radiotherapy: A quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67. J. Nucl. Med. 32, 2118-2123.
8. Martiat P., Ferrant A., Labar D., Cogneau M., Bol A., Michel C., Michaux J. L. and Sokal G. (1988) In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography. J. Nucl. Med. 29, 1633-1637.
9. 14C]uracils. J. Med. Chem. 30, 670-675.
10. Phillips F. S., Feinberg A., Chou T.-C., Vidal P. M., Su T.-L., Watanabe K. A. and Fox J. J. (1983) Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-β-D-arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-β-D-arabinofuranosyl)-5-idocytosine. Cancer Res. 43, 3619-3627.
11. Quackenbush R. C. and Shields A. F. (1988) Local re-utilization of thymidine in normal mouse tissues as measured with iododeoxyuridine. Cell Tiss. Kinetics 21, 381-387.
12. Shields A. F., Lim K., Grierson J., Link J. and Krohn K. A. (1990) Utilization of labeled thymidine in DNA synthesis: Studies for PET. J. Nucl. Med. 31, 337-342.
13. Strauss L. G. and Conti P. S. (1991) The applications of PET in clinical oncology. J. Nucl. Med. 32, 623-648.
14. Suzuki S., Misra H. K., Wiehe L. I., Knaus E. E. and Tyrrell D. L. (1987) A proposed mechanism for the selective inhibition of human cytomegalovirus replication by 1-(2′-deoxy-2′-fluoro-β-D-arabinosyl)-5-fluorouracil. Mol. Pharmacol. 31, 301-306.
15. Vander Borght T., Pauwels S., Lambotte L., Labar D., De Maeght S., Stroobandt G. and Laterre C. (1994) Brain tumor imaging with PET and 2-[carbon-11]thymidine. J. Nucl. Med. 35, 974-982.
16. Watanabe K. A., Reichman U., Hirota K., Lopez C. and Fox J. J. (1979) Nucleosides. 110. Synthesis and antiherpes virus activity of some 2′-fluoro-2′-deoxyarabinofuranosylpyrimidine nucleosides. J. Med. Chem. 22, 21-24.